___

• 1.Hosken R.A.: Possible mechanisms of mammalian immunocontraception. J Reprod Immunol, 2000a; 46: 103-124.
• 2.Barber M.R., and Fayrer-Hosken R.A.: Evaluation of somatic and reproductiveimmunotoxic effects of the porcine zona pellucida vaccination. J Exp Zool, 2000b; 286: 641-646.
• 3.Barber M.R., Lee S.M., Steffens W.L. Ard Z.M., and Fayrer-Hosken R.A.:Immunolocalization of zona pellucida antigens in the ovarian follicle of dogs, cats, horses and elephants. Theriogenology, 2001; 55: 1705-1 717.
• 4.Bradley M.P., Eade J., Penhale J., Bird P.: Vaccines for fertility regulation of wild and domestic species, h Biotechnol, 1999; 20:73 (2-3): 91-101.
• 5.Brandon C.I., Barber M.R., Brooks P.M., Fayrer-Hosken R.A.: Canine immunosterilization with a porcine zona pellucida vaccine. Theriogenology, 1998; 49 (1):262.
• 6.Brown R.G., Bowen W.D., Eddington J.D., Kimmins W.C., Mezei M., Parsons J.L., and Pohajdak B.: Evidence for an long lasting single administration contraceptive vaccines in wild grey seals. J Reprod Immunol, 1997; 35: 43-51.
• 7.Delsink A.K., van Altena J.J., Kirkpatrick J., Grobler D., Fayrer-Hosken R.A.: Field applications of immunocontraception in African elephants {Loxodonta africana). Reprod Suppl., 2002; 60: 117-24.
• 8.Delves P.J.: How far from a hormone-based contraceptive vaccine? J Reprod Immunol, 2004; 62: 69-78.
• 9.Dunbar B.S.: Ovarian antigens and infertility. Am J Reprod Immunol, 1989; 21: 28-31.
• 10.Dunbar B.S., Prasad S., Carin C, and Ms, Skinner S.M.: The Ovary as an Immune Target. J Soc Gynecol Invest, 2001; 8(1): 45.
• 11.Fayrer-Hosken R.A., Dookwah H.D., and Brandon C.I.: Immunocontrol in dogs. Anim Reprod Sci, 2000; 60, 365-373.
• 12.Fayrer-Hosken R.A., Barber M.R., Crane M., Collins T., and Hodgden R.: Differences in immunocontraceptive responses in white-tailed deer Odocoileus virginianus) and goats (Capra hircus). Reprod Suppl., 2002; 60:125-9.
• 13.Fayrer-Hosken R.A., Bertschinger H.J., Kirkpatrick J.F., Grobler D., Lamberski N., Honneyman G. and Ulrich T.: Contraceptive potential of the porcine zona pellucida vaccine in the African elephant (Loxodonta africana). Theriogenology, 1999; 52: 835-846.
• 14.Ferro V.A., Khan M.A.H., McAdam D., Colston A., Aughey E., Mullen A.B., Waterson M.M., Harvey M.J.A.: Efficiacy of an anti-fertility vaccine based on mammalian gonadotropin releasing hormone (GnRH-I) a histological comparison in male animals. Vet Immunol Immunop, 2004; 101: 73-86.
• 15.Gorman S.P., Levy J.K., Hampton A.L., Collante W.R., Harris A.L., and Brown R.G.: Evaluation of a porcine zona pellucida vaccine for the immunocontraception of domestic kittens (Felis catus). Theriogenology, 2002; 58(1): 135-49.
• 16.Griffin P.D.: Contraceptive vaccines. Erişim adresi: www.Gfmer.ch/Books/Reproductive- _health/Contraceptives_vaccines.html; 2004
• 17.Gupta S.K., Jethanandani P., Apfalzulkar A., Kaul R., and Santhanam R.: Prospects of zona pellucida glycoproteins as immunogens for contraceptive vaccine. Hum Reprod Update, 1997; 3 (4): 311-324.
• 18.Gupta S.K., Srivastava N., Choudhury S., Rath A., Sivapurapu N., Gahlay G.K., and Batra D.: Update on zona pellucida glycoproteins based contraceptive vaccine. J Reprod Immunol, 2004; 62: 79-89.
• 19.Hafez E.S.E.: Folliculogenesis, Egg Maturation and Ovulation. In: Reproduction in Farm Animals. Ed. Hafez, E.S.E., Philadelphia, Lea & Febiger, 1987, 130-167.
• 20.Ivanova M., Petrov M., Klissourska D., and Mallova M.: Contraceptive potential of porcine zona pellucida in cats. Theriogenology, 1995; 43: 969-81.
• 21.Kirkpatrick J.F., Turner J.W.: Reversibility of action and safety during pregnancy of immunization against porcine zona pellucida in wild mares (Equus caballus).Reprod Suppl. 2002; 60:197-202.
• 22.Kirkpatrick J.F., Turner J.W. Jr, Liu I.K., and Fayrer-Hosken R.A.: Applications of pig zona pellucida immunocontraception to wildlife fertility control. J Reprod Fertil Suppl., 1996; 50: 183-9.
• 23.Kirkpatrick J.F., Turner J.W. Jr, Liu I.K., Fayrer-Hosken R.A., and Rutberg A.T.: Case studies in wildlife immunocontraception: wild and feral equids and white-tailed deer. Reprod Fert Develop., 1997; 9(1): 105-10.
• 24.Ladd A., Tsong Y.Y., Walfield A.M., and Thau R.: Development of an antifertility vaccine for pets based on active immunization against luteinizing hormone-releasing hormone. Biol Reprod., 1994; 51: 1076-1083.
• 25.Levy J.K., Miller L.A., Crawford P.C., Ritchey J.W., Ross M.K., and Fagerstone K.A.: GnRH immunocontraception of male cats. Theriogenology, 2004; 62: 1116-1130.
• 26. Mahi-Brown C.A., Yanagimachi R., Hoffman J.C., and Huang Jr T.T.: Fertility control in the bitch active immunization with porcine zonae pellucidae: Use of different adjuvants and patterns of estradiol and progesterone levels in estrous cycles. Biol Reprod., 1985; 32: 761-772.
• 27.Miller L.A., Johns B.E., and Killian G.J.: Long-term effects of PZP immunization on reproduction in white-tailed deer. Vaccine, 2000; 18: 568-574
• 28.Rutberg A.T., Naugle R.E., Thiele L.A. and Liu I.K.M.: Effects of immunocontraception on a suburban population of white-tailed deer Odocoileus virginianus. Biol Conserv, 2004; 116:243-250.
• 29.Sacco A.G., Pierce D.L., Subramanian M.G., DeMayo F.J.: Ovaries remain functional in squirrel monkeys (Saimiri sciureus) immunized with porcine zona pellucida 55.000 macromolecule. Biol Reprod, 1987; 36: 481-490.
• 30.Sinowatz F., Toepfer-Petersen E., Koelle S., and Palma G.: Functional morphology of the zona pellucida. Anat Histol Embryol, 2001; 30,257-263